Digital Media Campaign for Tobacco Use Prevention
(DMCC Trial)
Trial Summary
What is the purpose of this trial?
There is little published data on exposure to and evaluations of large-scale, online tobacco control campaigns. This project addresses the gap. Under 2 specific aims, the investigators will identify the independent effects of varying levels of digital message exposure to promote anti-tobacco attitudes, beliefs, or behaviors among youth and young adults, first through a randomized experiment online, and second through a field-based evaluation. These studies will advance the science of digital health and have wide application to future campaigns.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment 'Digital Media Campaign for Tobacco Use Prevention'?
Research shows that tobacco control campaigns, including digital media efforts, can effectively influence tobacco use behaviors and promote quitting. These campaigns are also found to be cost-effective and can positively impact social norms and policy support, which helps sustain quitting and reduce tobacco uptake.12345
Is the digital media campaign for tobacco use prevention safe for humans?
How is the digital media campaign for tobacco use prevention different from other treatments for tobacco use?
The digital media campaign for tobacco use prevention is unique because it uses digital advertising to reach a wide audience, focusing on anti-vaping and anti-smoking messages through online platforms. Unlike traditional treatments that may involve medications or counseling, this approach leverages the power of digital media to influence social norms and behaviors, particularly among youth, by promoting awareness and prevention.235711
Research Team
Eligibility Criteria
This trial is for young adults aged 18-24 who are part of the Ipsos/Knowledge Panel. It's designed to evaluate if digital ads can influence anti-tobacco attitudes and behaviors. People outside this age group or not in the panel cannot participate.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Online Randomized Study
Conduct a 6-month controlled, online, randomized study to compare the effects of varying levels of digital media exposure on tobacco-related knowledge, attitudes, beliefs, and behavioral outcomes.
Field-based Randomized Trial
Evaluate a truth digital campaign to confirm the relationship between digital media exposure, message awareness, and tobacco-related outcomes.
Follow-up
Participants are monitored for changes in tobacco-related knowledge, attitudes, beliefs, and behaviors after the intervention.
Treatment Details
Interventions
- Anti-vaping and anti-smoking digital advertising (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
George Washington University
Lead Sponsor
Jeffrey S. Akman
George Washington University
Chief Executive Officer since 2017
MD from Albert Einstein College of Medicine
Holly Miller
George Washington University
Chief Medical Officer since 2009
MD from Albert Einstein College of Medicine
National Institutes of Health (NIH)
Collaborator
Dr. Jeanne Marrazzo
National Institutes of Health (NIH)
Chief Medical Officer
MD from University of California, Los Angeles
Dr. Jay Bhattacharya
National Institutes of Health (NIH)
Chief Executive Officer
MD, PhD from Stanford University